Related Experiment Video

Updated: Jul 8, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Multiple sclerosis genetics

J P McElroy1, J R Oksenberg

  • 1Department of Neurology, School of Medicine, University of California at San Francisco, San Francisco, CA 94143, USA.

Current Topics in Microbiology and Immunology
|January 29, 2008
PubMed

Insights

Multiple sclerosis (MS) genetics are complex, with the major histocompatibility complex (MHC) being a key factor. Further research using advanced technologies is needed to fully understand the genetic causes of MS.

Area of Science:

  • Genetics
  • Neuroimmunology
  • Complex Genetic Diseases

Background:

  • Multiple sclerosis (MS) is a complex genetic disorder influenced by gene-environment interactions.
  • The major histocompatibility complex (MHC) is the primary known genetic risk factor for MS.
  • Other genetic contributors to MS susceptibility remain largely unidentified.

Purpose of the Study:

  • To explore the genetic architecture of multiple sclerosis.
  • To identify genetic factors beyond the MHC contributing to MS.
  • To differentiate genetic causes from gene expression consequences in MS.

Main Methods:

  • Analysis of microarray gene-expression data.
  • Investigation of the major histocompatibility complex (MHC) and its haplotypes.
  • Discussion of emerging technologies for phenotype refinement (e.g., brain spectroscopy, PET, fMRI).

Main Results:

  • The MHC is the only consistently identified genomic region associated with MS.
  • Microarray studies have provided insights into MS pathways but have not pinpointed major MS loci.
  • Current methods struggle to distinguish genetic MS causes from gene expression changes due to the disease.

Conclusions:

  • Identifying all genetic contributors to MS requires advanced methodologies.
  • Refining MS phenotypes with neuroimaging and computational tools is crucial.
  • A comprehensive understanding of human genome architecture may unlock further MS genetic insights.

More Related Videos

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...